You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Correction: The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial

Article metrics

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: June 2019 to April 2024

AbstractFullPdf
Jun 2019858432
Jul 2019727210
Aug 201943435
Oct 201949497
Nov 201912123
Dec 2019993
Jan 202016152
Feb 202018172
Mar 202016156
May 2020551
Jun 2020223
Jul 202013131
Aug 202018186
Sep 202014141
Oct 202027275
Nov 202021215
Dec 202013134
Jan 2021551
Feb 2021221
Mar 202110104
Apr 2021771
May 2021114
Jun 202110100
Jul 20218810
Aug 2021546
Sep 2021004
Oct 20219914
Nov 2021121212
Dec 202110104
Jan 2022551
Feb 2022551
Mar 202217174
Apr 202212137
May 2022668
Jun 202211102
Jul 2022446
Aug 2022770
Sep 20223310
Oct 2022777
Nov 2022323
Dec 2022479
Jan 2023323
Feb 2023440
Mar 2023882
Apr 2023332
May 2023446
Jun 2023441
Jul 2023224
Aug 2023322
Sep 2023441
Oct 2023551
Nov 2023553
Dec 202310103
Jan 202413133
Feb 2024551
Mar 20247644
Apr 2024885
Total684678296